A randomised controlled trial to determine the effectiveness of bridging from emergency to regular contraception: the Bridge–it study

niversity of Edinburgh0 sites636 target enrollmentMarch 20, 2017

Overview

2019 Protocol article in https://pubmed.ncbi.nlm.nih.gov/31672711/ protocol (added 22/10/2020) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33189179/ results (added 16/11/2020) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33949940/ (added 06/05/2021) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35149574/ process evaluation (added 16/05/2023)

Registry

who.int

Start Date

March 20, 2017

End Date

June 26, 2020

Last Updated

2 years ago

Study Type

Interventional

Sex

Female

Sponsor

niversity of Edinburgh

•Current inclusion criteria as of 31/01/2019:
•1\. Intake of oral emergency contraception (1\.5 mg or 3 mg Levonorgestrel)
•2\. Capacity to give informed consent to participate in the trial which includes adherence to trial requirements
•3\. Willing to give contact details and be contacted at 4 months by phone or text or e\-mail or post
•4\. Willing to give identifying data sufficient to allow data linkage with NHS registries
•5\. Female aged 16 years or over
•Previous inclusion criteria:
•1\. Intake of oral emergency contraception (1\.5 mg Levonorgestrel)
•2\. Willing to participate in the trial
•3\. Willing to give contact details and be contacted at 4 and 12 months by phone or text or e\-mail or post

•Current exclusion criteria as of 31/01/2019:
•1 Contraindications to the POP (there are very few)
•2 On medication that interacts adversely with POP
•3\. Already using a hormonal method of contraception
•4\. Require interpreting services
•5\. If pharmacist has concerns about non\-consensual sex
•Previous exclusion criteria:
•1\. Not willing to provide contact details or personal data sufficient to allow identification/linkage with NHS registries
•2\. Contraindications to the POP (there are very few)
•3\. On medication that interacts adversely with POP